To make their discovery, researchers examined donated eye tissue from more than 100 people who had died with Alzheimer's, mild cognitive impairment or no signs of dementia. They were looking specifically for C. pneumoniae, because previous research has already linked it to Alzheimer's. The bacteria has also been detected in brain tissue from patients who died with the condition, sometimes found close to the sticky amyloid plaques and tangles believed to drive memory loss and confusion.
New therapies for Alzheimer's disease should target a particular gene linked to the condition, according to researchers who said most cases would never arise if its harmful effects were neutralised. The call to action follows the arrival of the first wave of drugs that aim to treat Alzheimer's patients by removing toxic proteins from the brain. While the drugs slow the disease down, the benefits are minor,
One in 10 people in the UK aged 70 and older could have Alzheimer's-like changes in their brain, according to the clearest, real-world picture of how common the disease's brain changes are in ordinary, older people. The detection of the proteins linked with the disease is not a diagnosis. But the findings indicate that more than 1 million over-70s would meet Nice's clinical criteria for anti-amyloid therapy a stark contrast to the 70,000 people the NHS has estimated could be eligible if funding were available.
Recent studies conclude that high glucose levels from sugar impacts your memory and impair cognition. In fact, individuals with diabetes, a condition that causes elevated high blood-sugar levels, are known to increase stress and have a higher risk of developing Alzheimer's disease, a form of dementia. It seems that the brain in type II diabetes, just like the body, has difficulty utilizing sugar for energy and this can lead to slower processing when it comes to memory retrieval.
Most healthy people have no issues telling left from right, but for some people (about 15 percent), left-right confusion is a somewhat common experience in their everyday lives. Common situations in which people confuse left and right every now and then include giving instructions about directions to somebody else who is driving a car, moving the wrong foot during dancing, or taking the wrong direction when hiking.
One of neurologist Anelyssa D'Abreu's least favorite tasks is giving her patients a dreaded diagnosis: early-stage Alzheimer's disease. But it's not quite as bad as it used to be. Today when they ask, "Is there anything we can do?" D'Abreu has a new answer: "Perhaps." Unlike a decade ago, when D'Abreu had little to offer her patients with Alzheimer's, there are now drugs that may impede the disease's progression.
Bob Milano, an Oakland kid who played catcher at Cal and then became the winningest baseball coach in school history, has died. He was 85. Milano retired following the 1999 season with 688 career victories. He was inducted to the Cal Athletics Hall of Fame in 2004 and had his jersey number 7 retired by the school. The school confirmed Milano's death on Monday afternoon.
We try to point out those bad papers because we still believe in science and want to make science better. But, I am very worried about how the work we do in pointing out bad papers is currently being misused, or even weaponized, to convince the general public that all science is bad.
There are differences in Alzheimer's patients and their gut microbiota, and that's been verified by many groups now. Prior research has shown that when you make changes in the gut microbiota of Alzheimer model mice, you in turn have effects on the pathology of the hallmarks of Alzheimer's - amyloid plaques and tau accumulation.
